JP2021515755A5 - - Google Patents

Info

Publication number
JP2021515755A5
JP2021515755A5 JP2020545154A JP2020545154A JP2021515755A5 JP 2021515755 A5 JP2021515755 A5 JP 2021515755A5 JP 2020545154 A JP2020545154 A JP 2020545154A JP 2020545154 A JP2020545154 A JP 2020545154A JP 2021515755 A5 JP2021515755 A5 JP 2021515755A5
Authority
JP
Japan
Prior art keywords
compound
salt according
salt
formula
alkyl
Prior art date
Application number
JP2020545154A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021515755A (ja
JP7251893B2 (ja
JPWO2019166937A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2019/051510 external-priority patent/WO2019166937A1/en
Publication of JP2021515755A publication Critical patent/JP2021515755A/ja
Publication of JPWO2019166937A5 publication Critical patent/JPWO2019166937A5/ja
Publication of JP2021515755A5 publication Critical patent/JP2021515755A5/ja
Application granted granted Critical
Publication of JP7251893B2 publication Critical patent/JP7251893B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020545154A 2018-02-28 2019-02-25 N-1分枝基を有する置換イミダゾ[4,5-c]キノリン化合物 Active JP7251893B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862636367P 2018-02-28 2018-02-28
US62/636,367 2018-02-28
PCT/IB2019/051510 WO2019166937A1 (en) 2018-02-28 2019-02-25 Substituted imidazo[4,5-c]quinoline compounds with an n-1 branched group

Publications (4)

Publication Number Publication Date
JP2021515755A JP2021515755A (ja) 2021-06-24
JPWO2019166937A5 JPWO2019166937A5 (https=) 2022-03-04
JP2021515755A5 true JP2021515755A5 (https=) 2022-03-04
JP7251893B2 JP7251893B2 (ja) 2023-04-04

Family

ID=65904502

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020545154A Active JP7251893B2 (ja) 2018-02-28 2019-02-25 N-1分枝基を有する置換イミダゾ[4,5-c]キノリン化合物

Country Status (7)

Country Link
US (1) US11370788B2 (https=)
EP (1) EP3759107B1 (https=)
JP (1) JP7251893B2 (https=)
CN (1) CN111788202B (https=)
CA (1) CA3092545A1 (https=)
ES (1) ES3003782T3 (https=)
WO (1) WO2019166937A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113906027A (zh) * 2019-06-12 2022-01-07 3M创新有限公司 具有N-1支链基团的苯乙基取代的咪唑并[4,5-c]喹啉化合物
EP4178676B1 (en) 2020-07-08 2026-04-15 Solventum Intellectual Properties Company N-1 branched imidazoquinolines, conjugates thereof, and methods
EP4263537A1 (en) * 2020-12-16 2023-10-25 3M Innovative Properties Company N-1 branched imidazoquinolines, conjugates thereof, and methods
CN116635394A (zh) * 2020-12-16 2023-08-22 3M创新有限公司 N-1支化咪唑并喹啉、其缀合物和方法
EP4448519A1 (en) * 2021-12-14 2024-10-23 Solventum Intellectual Properties Company N-1 triazole substituted imidazoquinolines, conjugates thereof, and methods

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3700674A (en) 1969-04-30 1972-10-24 American Cyanamid Co 4-alkylamino-3-nitroquinolines
IL73534A (en) * 1983-11-18 1990-12-23 Riker Laboratories Inc 1h-imidazo(4,5-c)quinoline-4-amines,their preparation and pharmaceutical compositions containing certain such compounds
US5389640A (en) 1991-03-01 1995-02-14 Minnesota Mining And Manufacturing Company 1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines
US5352784A (en) 1993-07-15 1994-10-04 Minnesota Mining And Manufacturing Company Fused cycloalkylimidazopyridines
EP0708772B1 (en) 1993-07-15 2000-08-23 Minnesota Mining And Manufacturing Company IMIDAZO [4,5-c]PYRIDIN-4-AMINES
KR100518903B1 (ko) 1996-10-25 2005-10-06 미네소타 마이닝 앤드 매뉴팩춰링 캄파니 Th2 매개 질병 및 관련 질병의 치료용 면역 반응 조절 화합물
JPH1180156A (ja) 1997-09-04 1999-03-26 Hokuriku Seiyaku Co Ltd 1−(置換アリール)アルキル−1h−イミダゾピリジン−4−アミン誘導体
UA67760C2 (uk) 1997-12-11 2004-07-15 Міннесота Майнінг Енд Мануфакчурінг Компані Імідазонафтиридин та тетрагідроімідазонафтиридин, фармацевтична композиція, спосіб індукування біосинтезу цитокінів та спосіб лікування вірусної інфекції, проміжні сполуки
US6110929A (en) 1998-07-28 2000-08-29 3M Innovative Properties Company Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof
US6451810B1 (en) 1999-06-10 2002-09-17 3M Innovative Properties Company Amide substituted imidazoquinolines
US6331539B1 (en) 1999-06-10 2001-12-18 3M Innovative Properties Company Sulfonamide and sulfamide substituted imidazoquinolines
US6677347B2 (en) * 2000-12-08 2004-01-13 3M Innovative Properties Company Sulfonamido ether substituted imidazoquinolines
US6664264B2 (en) * 2000-12-08 2003-12-16 3M Innovative Properties Company Thioether substituted imidazoquinolines
UA75622C2 (en) * 2000-12-08 2006-05-15 3M Innovative Properties Co Aryl ether substituted imidazoquinolines, pharmaceutical composition based thereon
US6677348B2 (en) * 2000-12-08 2004-01-13 3M Innovative Properties Company Aryl ether substituted imidazoquinolines
AU2004244962A1 (en) 2003-04-10 2004-12-16 3M Innovative Properties Company Delivery of immune response modifier compounds using metal-containing particulate support materials
BRPI0413558A (pt) 2003-08-12 2006-10-17 3M Innovative Properties Co compostos contendo imidazo substituìdo por hidroxilamina
US7544697B2 (en) 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
WO2005051317A2 (en) 2003-11-25 2005-06-09 3M Innovative Properties Company Substituted imidazo ring systems and methods
JP2007517035A (ja) * 2003-12-29 2007-06-28 スリーエム イノベイティブ プロパティズ カンパニー アリールアルケニルおよびアリールアルキニル置換されたイミダゾキノリン
WO2005094531A2 (en) 2004-03-24 2005-10-13 3M Innovative Properties Company Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
CA2571360C (en) 2004-06-18 2014-11-25 3M Innovative Properties Company Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines useful in inducing cytokine biosynthesis in animals
US8541438B2 (en) 2004-06-18 2013-09-24 3M Innovative Properties Company Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
US7915281B2 (en) 2004-06-18 2011-03-29 3M Innovative Properties Company Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and method
JP5543068B2 (ja) * 2004-12-30 2014-07-09 スリーエム イノベイティブ プロパティズ カンパニー キラル縮合[1,2]イミダゾ[4,5−c]環状化合物
KR20080083270A (ko) 2005-11-04 2008-09-17 콜레이 파마시티컬 그룹, 인코포레이티드 하이드록시 및 알콕시 치환된 1에이치 이미다조퀴놀린 및방법
ES2617451T3 (es) 2010-08-17 2017-06-19 3M Innovative Properties Company Composiciones lipidadas de compuestos modificadores de la respuesta inmunitaria, formulaciones, y métodos
WO2013033345A1 (en) 2011-08-30 2013-03-07 Regents Of The University Of Minnesota Immunomodulators and immunomodulator conjugates
MX377916B (es) 2014-04-22 2025-03-10 Hoffmann La Roche Compuestos 4-amino-imidazoquinolina.
US10730871B2 (en) * 2016-01-28 2020-08-04 Regents Of The University Of Minnesota Immunomodulators and immunomodulator conjugates
EP3728255B1 (en) 2017-12-20 2022-01-26 3M Innovative Properties Company Amide substituted imidazo[4,5-c]quinoline compounds with a branched chain linking group for use as an immune response modifier
EP3887369B1 (en) 2018-11-26 2024-05-08 Solventum Intellectual Properties Company N-1 branched alkyl ether substituted imidazo[4,5-c]quinoline compounds, compositions, and methods

Similar Documents

Publication Publication Date Title
JP2021515755A5 (https=)
JP2012532883A5 (https=)
JP2015512946A5 (https=)
JP2010527913A5 (https=)
JP2016503793A5 (https=)
JP2021512087A5 (https=)
JP2010515731A5 (https=)
JP2013503846A5 (https=)
JP2016518437A5 (https=)
JP2010504343A5 (https=)
CA2503884A1 (en) Cyclic sulfamides for inhibition of gamma-secretase
AR049446A1 (es) Preparacion de pregabalina ((s)-(+)-aminometil-5-metilhexanoico) y compuestos relacionados
AR040661A1 (es) Diclorhidrato cristalino de n-{2-[-((r)-2-hidroxi-2-feniletilamino)fenil]etil}-(r)-2hidroxi-2-(3-formamido-4-hidroxifenil)etilamina, agonista del receptor adrenergico beta 2
JP2008533152A5 (https=)
JP2009535358A5 (https=)
JP2002513793A5 (https=)
JP2012512863A5 (https=)
JP2020500916A5 (https=)
JP2014500861A5 (https=)
CA2744756A1 (en) Monocarbams and their use as antibacterial agent
JP2015516427A5 (https=)
RU2011133128A (ru) Противоопухолевые соединения дигидропиран-2-она
JP2014513051A5 (https=)
JP2021528421A5 (https=)
JP2013513607A5 (https=)